Related references
Note: Only part of the references are listed.Should cognitive impairment be included in the diagnostic criteria for schizophrenia?
RICHARD S.E. KEEFE
World Psychiatry (2015)
Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
Michael F. Green et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
Robert W. Buchanan et al.
SCHIZOPHRENIA BULLETIN (2011)
Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia
Robert H. Pietrzak et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies
Terry E. Goldberg et al.
NEUROPSYCHOPHARMACOLOGY (2010)
An investigation of 3 neurocognitive subtypes in schizophrenia
Narmeen Ammari et al.
SCHIZOPHRENIA RESEARCH (2010)
Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex
Paul Maruff et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2009)
Is executive impairment associated with schizophrenic syndromes? A meta-analysis
C. R. M. Dibben et al.
PSYCHOLOGICAL MEDICINE (2009)
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder:: an open randomised clinical trial
Rene S. Kahn et al.
LANCET (2008)
Cognitive, clinical, and functional characteristics of verbally superior schizophrenia patients
R. Walter Heinrichs et al.
NEUROPSYCHOLOGY (2008)
Systematic use of patient-rated depression severity monitoring: Is it helpful and feasible in clinical psychiatry?
Farifteh Firoozmand Duffy et al.
PSYCHIATRIC SERVICES (2008)
1-year follow-up study of cognitive function in first-episode non-affective psychosis
Jose M. Rodriguez-Sanchez et al.
SCHIZOPHRENIA RESEARCH (2008)
The evolution of drug development in schizophrenia: Past issues and future opportunities
William T. Carpenter et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The NIMH-MATRICS consensus statement on negative symptoms
B Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2006)
Subtyping schizophrenia: implications for genetic research
A. Jablensky
MOLECULAR PSYCHIATRY (2006)
Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions
AFT Arnsten et al.
BIOLOGICAL PSYCHIATRY (2005)
World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia
P Falkai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2005)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
Brief cognitive assessment schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status
CM Wilk et al.
SCHIZOPHRENIA RESEARCH (2004)
A meta-analysis of the efficacy of second-generation antipsychotics
JM Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Context-processing deficits in schizophrenia: Diagnostic specificity, 4-week course, and relationships to clinical symptoms
DM Barch et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2003)
Clinical trials in psychiatry: Do results apply to practice?
MV Seeman
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2001)
Age and neuropsychologic function in schizophrenia: A decline in executive abilities beyond that observed in healthy volunteers
R Fucetola et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
